Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.
Clinical trial NCT04802070 · COMPLETED
Trial details
- NCT number
- NCT04802070
- Sponsor
- Prof. Franca Fagioli
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2023-03-16
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.